$GALT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GALECTIN THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GALECTIN THERAPEUTICS INC. Get notifications about new insider transactions in GALECTIN THERAPEUTICS INC for free.
Page: < prev 1 2 3 4 5 6 ... 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 18 2019 | GALT | GALECTIN THERAPEUT ... | ELDRED KARY | Director | Option Exercise | A | 4.72 | 25,000 | 118,000 | 25,000 | |
| Jan 18 2019 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Option Exercise | A | 4.72 | 25,000 | 118,000 | 25,000 | |
| Jan 18 2019 | GALT | GALECTIN THERAPEUT ... | SHULMAN STEPHEN | Director | Option Exercise | A | 4.72 | 25,000 | 118,000 | 25,000 | |
| Jan 18 2019 | GALT | GALECTIN THERAPEUT ... | OMENN GILBERT S | Director | Option Exercise | A | 4.72 | 35,000 | 165,200 | 35,000 | |
| Jan 18 2019 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Option Exercise | A | 4.72 | 40,000 | 188,800 | 40,000 | |
| Jan 18 2019 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Option Exercise | A | 4.72 | 35,000 | 165,200 | 35,000 | |
| Jan 18 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | A | 4.72 | 25,000 | 118,000 | 25,000 | |
| Jan 18 2019 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | A | 4.72 | 50,000 | 236,000 | 50,000 | |
| Jan 18 2019 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Executive Off ... | Option Exercise | A | 4.72 | 70,000 | 330,400 | 70,000 | |
| Sep 26 2018 | GALT | GALECTIN THERAPEUT ... | ELDRED KARY | Director | Buy | P | 6.10 | 2,000 | 12,200 | 41,382 | 39.4 K to 41.4 K (+5.08 %) |
| Sep 11 2018 | GALT | GALECTIN THERAPEUT ... | OMENN GILBERT S | Director | Sell | S | 6.00 | 8,370 | 50,220 | 48,191 | 56.6 K to 48.2 K (-14.80 %) |
| Sep 11 2018 | GALT | GALECTIN THERAPEUT ... | OMENN GILBERT S | Director | Sell | S | 6.03 | 11,000 | 66,365 | 56,561 | 67.6 K to 56.6 K (-16.28 %) |
| Sep 06 2018 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | M | 0.89 | 6,000 | 5,340 | 16,500 | |
| Sep 06 2018 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Sell | S | 6.58 | 11,900 | 78,256 | 20,581 | 32.5 K to 20.6 K (-36.64 %) |
| Sep 06 2018 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Buy | M | 0.00 | 6,000 | 0 | 32,481 | 26.5 K to 32.5 K (+22.66 %) |
| Sep 04 2018 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | M | 0.89 | 29,000 | 25,810 | 22,500 | |
| Sep 04 2018 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Sell | S | 6.08 | 58,100 | 353,312 | 26,481 | 84.6 K to 26.5 K (-68.69 %) |
| Sep 04 2018 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Buy | M | 0.00 | 29,000 | 0 | 84,581 | 55.6 K to 84.6 K (+52.18 %) |
| Jun 26 2018 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | Director | Buy | P | 7.06 | 1,000 | 7,058 | 51,480 | 50.5 K to 51.5 K (+1.98 %) |
| Jun 21 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | M | 4.41 | 97,267 | 428,947 | 0 | |
| Jun 21 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | M | 3.45 | 26,000 | 89,700 | 0 | |
| Jun 21 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | M | 4.41 | 102,733 | 453,053 | 97,267 | |
| Jun 21 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Sell | S | 8.08 | 97,267 | 786,034 | 1,260 | 98.5 K to 1.3 K (-98.72 %) |
| Jun 21 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Buy | M | 4.41 | 97,267 | 428,947 | 98,527 | 1.3 K to 98.5 K (+7,719.60 %) |
| Jun 21 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Sell | S | 9.01 | 128,733 | 1,159,987 | 1,260 | 130 K to 1.3 K (-99.03 %) |
| Jun 21 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Buy | M | 3.45 | 26,000 | 89,700 | 129,993 | 104 K to 130 K (+25.00 %) |
| Jun 21 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Buy | M | 4.41 | 102,733 | 453,053 | 103,993 | 1.3 K to 104 K (+8,153.41 %) |
| Jun 20 2018 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Sell | S | 9.06 | 60,000 | 543,600 | 2,649,786 | 2.7 M to 2.6 M (-2.21 %) |
| Jun 20 2018 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Sell | S | 8.47 | 15,475 | 131,073 | 2,709,786 | 2.7 M to 2.7 M (-0.57 %) |
| Jun 20 2018 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Sell | S | 8.48 | 44,525 | 377,572 | 2,725,261 | 2.8 M to 2.7 M (-1.61 %) |
| Jun 20 2018 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Sell | S | 7.99 | 31,860 | 254,561 | 2,769,786 | 2.8 M to 2.8 M (-1.14 %) |
| Jun 20 2018 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 9.06 | 60,000 | 543,600 | 2,649,786 | 2.7 M to 2.6 M (-2.21 %) |
| Jun 20 2018 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 8.47 | 15,475 | 131,073 | 2,709,786 | 2.7 M to 2.7 M (-0.57 %) |
| Jun 20 2018 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 8.48 | 44,525 | 377,572 | 2,725,261 | 2.8 M to 2.7 M (-1.61 %) |
| Jun 20 2018 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 7.99 | 31,860 | 254,561 | 2,769,786 | 2.8 M to 2.8 M (-1.14 %) |
| Jun 18 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Executive Off ... | Option Exercise | A | 6.17 | 35,000 | 215,950 | 35,000 | |
| Jun 15 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Option Exercise | M | 0.87 | 100,000 | 87,000 | 50,000 | |
| Jun 15 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Sell | S | 7.51 | 100,000 | 751,000 | 107,333 | 207.3 K to 107.3 K (-48.23 %) |
| Jun 15 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Buy | M | 0.87 | 100,000 | 87,000 | 207,333 | 107.3 K to 207.3 K (+93.17 %) |
| Jun 14 2018 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 7.97 | 28,140 | 224,276 | 2,801,646 | 2.8 M to 2.8 M (-0.99 %) |
| Jun 14 2018 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 7.47 | 60,000 | 448,200 | 2,829,786 | 2.9 M to 2.8 M (-2.08 %) |
| Jun 14 2018 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 7.09 | 60,000 | 425,400 | 2,889,786 | 2.9 M to 2.9 M (-2.03 %) |
| Jun 14 2018 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 6.59 | 60,000 | 395,400 | 2,949,786 | 3 M to 2.9 M (-1.99 %) |
| Jun 14 2018 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Sell | S | 7.97 | 28,140 | 224,276 | 2,801,646 | 2.8 M to 2.8 M (-0.99 %) |
| Jun 14 2018 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Sell | S | 7.47 | 60,000 | 448,200 | 2,829,786 | 2.9 M to 2.8 M (-2.08 %) |
| Jun 14 2018 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Sell | S | 7.09 | 60,000 | 425,400 | 2,889,786 | 2.9 M to 2.9 M (-2.03 %) |
| Jun 14 2018 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Sell | S | 6.59 | 60,000 | 395,400 | 2,949,786 | 3 M to 2.9 M (-1.99 %) |
| Jun 14 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | M | 1.37 | 9,294 | 12,733 | 8,706 | |
| Jun 14 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Sell | S | 7.01 | 9,294 | 65,167 | 1,260 | 10.6 K to 1.3 K (-88.06 %) |
| Jun 14 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Buy | M | 1.37 | 9,294 | 12,733 | 10,554 | 1.3 K to 10.6 K (+737.62 %) |
| Jun 14 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 3.45 | 25,544 | 88,127 | 12,456 | |
| Jun 14 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Sell | S | 7.79 | 30,918 | 240,916 | 0 | 30.9 K to 0 (-100.00 %) |
| Jun 14 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 0.00 | 25,544 | 0 | 30,918 | 5.4 K to 30.9 K (+475.33 %) |
| Jun 14 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Sell | S | 6.50 | 12,780 | 83,070 | 5,374 | 18.2 K to 5.4 K (-70.40 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 6.08 | 60,000 | 364,800 | 3,009,786 | 3.1 M to 3 M (-1.95 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 5.64 | 50,000 | 282,000 | 3,069,786 | 3.1 M to 3.1 M (-1.60 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Sell | S | 6.08 | 60,000 | 364,800 | 3,009,786 | 3.1 M to 3 M (-1.95 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Sell | S | 5.64 | 50,000 | 282,000 | 3,069,786 | 3.1 M to 3.1 M (-1.60 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Option Exercise | M | 0.87 | 70,000 | 60,900 | 150,000 | |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Sell | S | 5.86 | 70,000 | 409,997 | 107,333 | 177.3 K to 107.3 K (-39.47 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Buy | M | 0.87 | 70,000 | 60,900 | 177,333 | 107.3 K to 177.3 K (+65.22 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 1.37 | 29,294 | 40,133 | 8,706 | |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 0.87 | 50,000 | 43,500 | 0 | |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Sell | S | 6.50 | 10,760 | 69,940 | 18,154 | 28.9 K to 18.2 K (-37.21 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Sell | S | 5.77 | 104,294 | 602,048 | 28,914 | 133.2 K to 28.9 K (-78.29 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 1.37 | 29,294 | 40,133 | 184,099 | 154.8 K to 184.1 K (+18.92 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 0.87 | 50,000 | 43,500 | 103,914 | 53.9 K to 103.9 K (+92.74 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | M | 1.37 | 20,000 | 27,400 | 18,000 | |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | M | 0.87 | 100,000 | 87,000 | 0 | |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Sell | S | 6.38 | 20,000 | 127,500 | 1,260 | 21.3 K to 1.3 K (-94.07 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Buy | M | 1.37 | 20,000 | 27,400 | 21,260 | 1.3 K to 21.3 K (+1,587.30 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Sell | S | 5.75 | 100,000 | 575,000 | 1,260 | 101.3 K to 1.3 K (-98.76 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Buy | M | 0.87 | 100,000 | 87,000 | 101,260 | 1.3 K to 101.3 K (+7,936.51 %) |
| Jun 08 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 0.87 | 25,701 | 22,360 | 50,000 | |
| Jun 08 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 2.32 | 75,190 | 174,441 | 0 | |
| Jun 08 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 0.87 | 4,898 | 4,261 | 75,701 | |
| Jun 08 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 2.32 | 4,180 | 9,698 | 75,190 | |
| Jun 08 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Sell | S | 5.21 | 100,891 | 525,269 | 53,914 | 154.8 K to 53.9 K (-65.17 %) |
| Jun 08 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 0.87 | 25,701 | 22,360 | 154,805 | 129.1 K to 154.8 K (+19.91 %) |
| Jun 08 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 2.32 | 75,190 | 174,441 | 129,104 | 53.9 K to 129.1 K (+139.46 %) |
| Jun 08 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Sell | S | 5.15 | 9,078 | 46,752 | 53,914 | 63 K to 53.9 K (-14.41 %) |
| Jun 08 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 0.87 | 4,898 | 4,261 | 62,992 | 58.1 K to 63 K (+8.43 %) |
| Jun 08 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 2.32 | 4,180 | 9,698 | 58,094 | 53.9 K to 58.1 K (+7.75 %) |
| Jun 06 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 0.87 | 4,294 | 3,736 | 80,599 | |
| Jun 06 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 2.32 | 5,630 | 13,062 | 79,370 | |
| Jun 06 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 0.87 | 5,407 | 4,704 | 84,893 | |
| Jun 06 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 2.32 | 5,500 | 12,760 | 85,000 | |
| Jun 06 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Sell | S | 5.16 | 9,924 | 51,183 | 53,914 | 63.8 K to 53.9 K (-15.55 %) |
| Jun 06 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 0.87 | 4,294 | 3,736 | 69,338 | 65 K to 69.3 K (+6.60 %) |
| Jun 06 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 2.32 | 5,630 | 13,062 | 65,044 | 59.4 K to 65 K (+9.48 %) |
| Jun 06 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Sell | S | 5.15 | 10,907 | 56,173 | 53,914 | 64.8 K to 53.9 K (-16.83 %) |
| Jun 06 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 0.87 | 5,407 | 4,704 | 64,821 | 59.4 K to 64.8 K (+9.10 %) |
| Jun 06 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 2.32 | 5,500 | 12,760 | 59,414 | 53.9 K to 59.4 K (+10.20 %) |
| Jun 05 2018 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Sell | S | 5.13 | 8,093 | 41,517 | 3,119,786 | 3.1 M to 3.1 M (-0.26 %) |
| Jun 05 2018 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Sell | S | 5.12 | 41,907 | 214,564 | 3,161,693 | 3.2 M to 3.2 M (-1.31 %) |
| Jun 05 2018 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 5.13 | 8,093 | 41,517 | 3,119,786 | 3.1 M to 3.1 M (-0.26 %) |
| Jun 05 2018 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 5.12 | 41,907 | 214,564 | 3,161,693 | 3.2 M to 3.2 M (-1.31 %) |
| Jun 04 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | M | 0.87 | 46,651 | 40,586 | 100,000 | |
| Jun 04 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Sell | S | 5.00 | 46,651 | 233,255 | 1,260 | 47.9 K to 1.3 K (-97.37 %) |
| Jun 04 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Buy | M | 0.87 | 46,651 | 40,586 | 47,911 | 1.3 K to 47.9 K (+3,702.46 %) |
| Jun 04 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 0.87 | 59,700 | 51,939 | 90,300 | |
| Jun 04 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 2.32 | 9,500 | 22,040 | 90,500 | |
| Jun 04 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 2.32 | 50,000 | 116,000 | 100,000 | |
| Jun 04 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Sell | S | 5.10 | 69,200 | 352,920 | 53,914 | 123.1 K to 53.9 K (-56.21 %) |
| Jun 04 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 0.87 | 59,700 | 51,939 | 123,114 | 63.4 K to 123.1 K (+94.14 %) |
| Jun 04 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 2.32 | 9,500 | 22,040 | 63,414 | 53.9 K to 63.4 K (+17.62 %) |
| Jun 04 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Sell | S | 5.00 | 50,000 | 250,000 | 53,914 | 103.9 K to 53.9 K (-48.12 %) |
| Jun 04 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 2.32 | 50,000 | 116,000 | 103,914 | 53.9 K to 103.9 K (+92.74 %) |
| May 29 2018 | GALT | GALECTIN THERAPEUT ... | ELDRED KARY | Director | Option Exercise | A | 4.16 | 46,875 | 195,000 | 46,875 | |
| May 24 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | A | 4.16 | 90,000 | 374,400 | 90,000 | |
| May 24 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | A | 4.16 | 90,000 | 374,400 | 90,000 | |
| May 24 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Option Exercise | A | 4.16 | 125,000 | 520,000 | 125,000 | |
| Apr 18 2018 | GALT | GALECTIN THERAPEUT ... | ZUCCONI THEODORE DANIEL | Director | Option Exercise | M | 0.89 | 4,000 | 3,560 | 27,250 | |
| Apr 18 2018 | GALT | GALECTIN THERAPEUT ... | ZUCCONI THEODORE DANIEL | Director | Sell | S | 3.58 | 4,000 | 14,320 | 1,083 | 5.1 K to 1.1 K (-78.69 %) |
| Apr 18 2018 | GALT | GALECTIN THERAPEUT ... | ZUCCONI THEODORE DANIEL | Director | Buy | M | 0.89 | 4,000 | 3,560 | 5,083 | 1.1 K to 5.1 K (+369.34 %) |
| Apr 06 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | M | 0.87 | 3,349 | 2,914 | 146,651 | |
| Apr 06 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Sell | S | 5.00 | 3,349 | 16,745 | 1,260 | 4.6 K to 1.3 K (-72.66 %) |
| Apr 06 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Buy | M | 0.87 | 3,349 | 2,914 | 4,609 | 1.3 K to 4.6 K (+265.79 %) |
| Feb 02 2018 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Buy | P | 4.10 | 2,000 | 8,191 | 16,000 | 14 K to 16 K (+14.29 %) |
| Feb 02 2018 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Buy | P | 4.10 | 2,000 | 8,191 | 16,000 | 14 K to 16 K (+14.29 %) |
| Jan 29 2018 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Sell | S | 5.35 | 39,300 | 210,255 | 3,120,984 | 3.2 M to 3.1 M (-1.24 %) |
| Jan 29 2018 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Sell | S | 5.45 | 205,144 | 1,118,035 | 3,160,284 | 3.4 M to 3.2 M (-6.10 %) |
| Jan 29 2018 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 5.35 | 39,300 | 210,255 | 3,120,984 | 3.2 M to 3.1 M (-1.24 %) |
| Jan 29 2018 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 5.45 | 205,144 | 1,118,035 | 3,160,284 | 3.4 M to 3.2 M (-6.10 %) |
| Jan 17 2018 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | A | 5.87 | 90,000 | 528,300 | 90,000 | |
| Jan 17 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Option Exercise | A | 5.87 | 125,000 | 733,750 | 125,000 | |
| Jan 17 2018 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | A | 5.87 | 90,000 | 528,300 | 90,000 | |
| Dec 18 2017 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | A | 2.39 | 77,250 | 184,628 | 77,250 | |
| Dec 18 2017 | GALT | GALECTIN THERAPEUT ... | SHULMAN STEPHEN | Director | Option Exercise | A | 2.39 | 46,875 | 112,031 | 46,875 | |
| Dec 18 2017 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Option Exercise | A | 2.39 | 62,250 | 148,778 | 62,250 | |
| Dec 18 2017 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Option Exercise | A | 2.39 | 46,875 | 112,031 | 46,875 | |
| Dec 18 2017 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Option Exercise | A | 2.39 | 46,875 | 112,031 | 46,875 | |
| Dec 18 2017 | GALT | GALECTIN THERAPEUT ... | ZUCCONI THEODORE DANIEL | Director | Option Exercise | A | 2.39 | 46,875 | 112,031 | 46,875 | |
| Dec 18 2017 | GALT | GALECTIN THERAPEUT ... | OMENN GILBERT S | Director | Option Exercise | A | 2.39 | 62,250 | 148,778 | 62,250 | |
| Dec 18 2017 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Option Exercise | A | 2.39 | 46,875 | 112,031 | 46,875 | |
| Dec 18 2017 | GALT | GALECTIN THERAPEUT ... | Uihlein Richard E | Director | Grant | A | 2.39 | 14,644 | 34,999 | 2,524,553 | 2.5 M to 2.5 M (+0.58 %) |
| Dec 18 2017 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | Director | Option Exercise | A | 2.39 | 62,250 | 148,778 | 62,250 | |
| Dec 18 2017 | GALT | GALECTIN THERAPEUT ... | LEWIS JOEL | Director | Grant | A | 2.39 | 23,013 | 55,001 | 50,880 | 27.9 K to 50.9 K (+82.58 %) |
| Dec 08 2017 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Buy | P | 1.64 | 400 | 657 | 28,043 | 27.6 K to 28 K (+1.45 %) |
| Dec 08 2017 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Buy | P | 1.63 | 8,000 | 13,005 | 8,000 | 0 to 8 K |
| Dec 08 2017 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Buy | P | 1.85 | 7,000 | 12,972 | 55,581 | 48.6 K to 55.6 K (+14.41 %) |
| Sep 08 2017 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Buy | J | 2.42 | 95,205 | 230,396 | 3,135,150 | 3 M to 3.1 M (+3.13 %) |
| Sep 08 2017 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Buy | J | 1.98 | 116,151 | 229,979 | 3,039,945 | 2.9 M to 3 M (+3.97 %) |
| Sep 08 2017 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Buy | J | 6.00 | 1,000 | 6,000 | 888,630 | 887.6 K to 888.6 K (+0.11 %) |
| Sep 08 2017 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | J | 2.42 | 95,205 | 230,396 | 3,135,150 | 3 M to 3.1 M (+3.13 %) |
| Sep 08 2017 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | J | 1.98 | 116,151 | 229,979 | 3,039,945 | 2.9 M to 3 M (+3.97 %) |
| May 24 2017 | GALT | GALECTIN THERAPEUT ... | ZUCCONI THEODORE DANIEL | Director | Buy | P | 2.27 | 1,000 | 2,270 | 1,083 | 83 to 1.1 K (+1,204.82 %) |
| Feb 01 2017 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Director | Buy | J | 1.01 | 211,876 | 213,995 | 3,452,303 | 3.2 M to 3.5 M (+6.54 %) |
| Feb 01 2017 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | J | 1.01 | 211,876 | 213,995 | 3,452,303 | 3.2 M to 3.5 M (+6.54 %) |
| Jan 20 2017 | GALT | GALECTIN THERAPEUT ... | ZUCCONI THEODORE DANIEL | Director | Option Exercise | S | 5.63 | 85 | 479 | 38 |